U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229716) titled 'Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects' on Nov. 13.
Brief Summary: This study aims to evaluate the interaction of oral HRS-9813 capsules with pirfenidone and nintedanib on the pharmacokinetics of healthy subjects.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Pulmonary Fibrosis
Intervention:
DRUG: HRS-9813 Capsule
HRS-9813 capsule, specified dose on specified days.
DRUG: Nintedanib Soft Capsules
Nintedanib soft capsules, specified dose on specified days.
DRUG: Pirfenidone Tablets
Pirfenidone tablets, specified dose on specified days.
Recruitment Sta...